The New York Times·1 min read·easy
The F.D.A. Approves a New Pill to Slash Cholesterol Levels
✦AI Summary
The Food and Drug Administration (FDA) has approved a new daily pill, enlicitide (brand name Lipfendra), designed to lower cholesterol levels more effectively than existing statin medications. This approval marks a significant advancement in cholesterol management.
The Food and Drug Administration approved a daily pill on Thursday that can lower cholesterol levels far below what can be achieved with statins, the cheap cholesterol-reducing pills. The drug, enlicitide, whose brand name is Lipfendra, is made by th... [1665 chars]
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in